Clinical trial

Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

NCT00652288

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-04-01

PhasePHASE1

Study timeline

Study start (unknown)2007-04-01Date precision: month

Registry last updated2016-09-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type Iunresolved

Interventions

Insulin analogs (Lispro and Aspart)DRUG

Insulin analogs (Aspart and Detemir)DRUG

Insulin analogs (Lispro and Glargine)DRUG

Sponsors & collaborators

Yale Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00652288 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.